News | December 20, 2023
Asahi Kasei opens new Bioprocess Technical Center in China
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Minister was briefed on the nationwide dengue situation
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Subscribe To Our Newsletter & Stay Updated
